Quest Diagnostics (DGX) PT Raised to $197 at Baird
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $236.04 -0.73%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Baird analyst Eric Coldwell raised the price target on Quest Diagnostics (NYSE: DGX) to $197.00 (from $194.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Quest Diagnostics (DGX) Declares $0.86 Quarterly Dividend; 1.4% Yield
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
